GSK $30 Billion U.S. Investment in Pharma
The news of GSK’s $30 billion U.S. investment is making waves across the pharmaceutical and manufacturing world. Over the next five years, the company plans to strengthen its research and development presence while expanding critical manufacturing facilities. This massive commitment includes a new $1.2 billion facility in Pennsylvania dedicated to respiratory and cancer treatments, along…









